With approval of the updated COVID-19 vaccine coming weeks later than in the past, the fall vaccine season has started slowly, according to Pfizer.
The sales of Pfizer’s Comirnaty shots sank 25% after the U.S. government narrowed recommendations of who needs the jab earlier this year.